Incanthera PLC Result of AGM

RNS Number : 6393I

Incanthera PLC

17 October 2024

Goal Group

17 October 2024

Incanthera plc

("Incanthera" the "Company")

Result of AGM 2024

Incanthera plc (AQSE: INC), the company focused on innovative technologies in dermatology and oncology, held its AGM earlier today. The Company is pleased to announce that all resolutions were duly passed.

The Company would like to thank all Shareholders who returned their Proxy form and attended in person.

For further information please contact:

Incanthera plc

www.incanthera.com

Tim McCarthy, Chairman

tim.mccarthy@incanthera.com

Simon Ward, Chief Executive Officer

simon.ward@incanthera.com

Suzanne Brocks, Head of Communications

suzanne.brocks@incanthera.com

+44 (0) 7831 675747

+44 (0) 7747 625506

+44 (0) 7776 234600

Aquis Exchange Corporate Adviser:

Cairn Financial Advisers LLP

Jo Turner / Liam Murray / Ed Downes

+44 (0) 20 7213 0880

Broker:

Stanford Capital Partners Ltd

Patrick Claridge / Bob Pountney

+44 (0) 20 3650 3650/51

Notes to Editors

About Incanthera plc

Incanthera is a specialist company focused on innovative technologies in dermatology and oncology. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading specialists and academic institutions as well as its in-house development team.

The Company originated from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford. Incanthera's strategy is to develop each candidate in its portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.

For more information on the Company please visit: www.incanthera.com

@incantheraplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGPGWAUUPCGGM

Incanthera (AQSE:INC)
Historical Stock Chart
From Nov 2024 to Dec 2024